Letter from the Editor EditorProf. Marc P. Bonaca, University of Colorado, USA ConferenceISTH 2020 8 September, 2020 17:04
ISTH 2020 Highlights Podcast Presented ByDr Rachel Giles, Medicom ConferenceISTH 2020 7 September, 2020 21:10
Novel gene therapy leads to normal FIX activity levels in severe haemophilia B Presented ByDr Pratima Chowdary, Royal Free London NHS Foundation Trust, United Kingdom TrialPhase 1/2, B-AMAZE ConferenceISTH 2020 8 September, 2020 14:31
Haemophilia gene therapy: progress and obstacles Presented ByProf. Amit Nathwani, University College London, United Kingdom TrialReview study ConferenceISTH 2020 8 September, 2020 14:27
Recombinant factor VIII safe and effective in PUPs A-LONG study Presented ByDr Christoph Königs, University Hospital Frankfurt, Germany TrialPhase 3, PUPs A-LONG ConferenceISTH 2020 8 September, 2020 14:22
Finding the sweet spot of anticoagulation in AF patients with ACS Presented ByProf. Renato D. Lopes, Duke University School of Medicine, USA TrialAUGUSTUS ConferenceISTH 2020 8 September, 2020 14:59
Lower embryopathy risk with DOAC versus VKA during pregnancy Presented ByDr Jan Beyer-Westendorf, UNI-Klinikum Carl Gustav Carus Medizinische Klinik I, Germany ConferenceISTH 2020 8 September, 2020 14:53
Higher thrombotic risk in NSCLC patient with ALK rearrangement Presented ByDr Hanny Al-Samkari, Massachusetts General Hospital, USA ConferenceISTH 2020 8 September, 2020 14:41
Crosstalk between inflammation and coagulation in severe COVID-19 infections Presented ByProf. Roberta Gualtierotti, University of Milan, Italy ConferenceISTH 2020 8 September, 2020 15:21
COVID-19 associated with higher VTE rates relative to influenza Presented ByDr Milou Stals, Leiden University Medical Centre, the Netherlands ConferenceISTH 2020 8 September, 2020 15:18
Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients Presented ByDr Hanny Al-Samkari, Massachusetts General Hospital, USA TrialCohort study ConferenceISTH 2020 8 September, 2020 15:15
COVID-19 not associated with heightened VTE risk after discharge Presented ByDr Matthias Engelen, University Hospital Leuven, Belgium ConferenceISTH 2020 8 September, 2020 15:09
Residual pulmonary obstruction may predict risk of VTE recurrence Presented ByDr Robin Chaux, University Hospital St. Etienne, France ConferenceISTH 2020 8 September, 2020 15:50
Less diagnostic delay in CTEPH diagnosis with novel algorithm Presented ByDr Gudula Boon, Leiden University Medical Center, the Netherlands TrialInSHAPE II ConferenceISTH 2020 8 September, 2020 15:47
Risk of checkpoint inhibitor-associated thromboembolic events important for cancer prognosis Presented ByDr Florian Moik, Medical university of Vienna, Austria TrialCohort study ConferenceISTH 2020 8 September, 2020 15:44
Surgical bleeding risk most important determinant of bleeding outcomes Presented ByDr Kira MacDougall, Staten Island University Hospital, USA TrialPAUSE ConferenceISTH 2020 8 September, 2020 16:27
Similar bleeding rates in patients with VTE and AF treated with DOACs Presented ByDr Farès Moustafa, CHU Clermont Ferrand, France ConferenceISTH 2020 8 September, 2020 16:21
Physical rehabilitation improves health outcomes after pulmonary embolism Presented ByDr Stephan Nopp, Medical University Vienna, Austria ConferenceISTH 2020 8 September, 2020 16:18
Guidelines adherence reduces bleeding risk after surgery and childbirth for VWD patients Presented ByDr Brian Craven, Royal Free London NHS Foundation Trust, United Kingdom ConferenceISTH 2020 8 September, 2020 16:15
Factor V Leiden mutation linked to atrial fibrillation Presented ByErin Mathiesen Hald, UiT The Arctic University of Norway, Tromsø, Norway TrialCohort study, Tromsø Study ConferenceISTH 2020 8 September, 2020 16:08
Increased rates of arterial thromboembolism in cancer patients Presented ByDr Frits Mulder, Amsterdam UMC, University of Amsterdam, the Netherlands ConferenceISTH 2020 8 September, 2020 15:59